Koninklijke BAM Groep nv (KBAGF) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4707449-koninklijke-bam-groep-nv-kbagf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Jul 27, 2024 - Koninklijke BAM Groep nv (OTCPK:KBAGF) Q2 2024 Earnings Call Transcript July 25, 2024 4:00 AM ETCompany ParticipantsMichel Aupers - IR ManagerRuud Joosten -...
0
Novartis AG (NVS) Investor Event at ASCO Conference Call (Transcript)
https://seekingalpha.com/article/4697234-novartis-ag-nvs-investor-event-asco-conference-call-transcript?source=feed_sector_transcripts
Jun 03, 2024 -
0
NV Bekaert SA (BEKSF) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4707331-nv-bekaert-sa-beksf-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Jul 26, 2024 - NV Bekaert SA (OTCPK:BEKSF) Q2 2024 Results Conference Call July 24, 2024 4:00 AM ETCompany ParticipantsGuy Marks - Investor RelationsYves Kerstens - Chief...
0
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
https://www.fool.com/investing/2024/08/18/2-unstoppable-healthcare-stocks-to-buy-right-now/?source=iedfolrf0000001
Aug 18, 2024 - These companies' growth paths should only be briefly interrupted by headwinds.
0
Anheuser-Busch InBev/NV (BUD) Q3 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/10/31/anheuser-busch-inbevnv-bud-q3-2024-earnings-call-t/?source=iedfolrf0000001
Oct 31, 2024 - BUD earnings call for the period ending September 30, 2024.
0
Novartis (NVS) Gets FDA Nod for Rare Blood Disorder Drug
https://www.zacks.com/stock/news/2194094/novartis-nvs-gets-fda-nod-for-rare-blood-disorder-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2194094
Dec 06, 2023 - Novartis (NVS) obtains FDA approval for Fabhalta, the first oral monotherapy for treating adults with PNH.
0
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnj-s-2024-view-lly-nvs-get-fda-nod?cid=CS-ZC-FT-analyst_blog|stock_roundup-2195315
Dec 08, 2023 - AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.
0
Arcadis NV (ARCAY) Is a Great Choice for 'Trend' Investors, Here's Why
https://www.zacks.com/stock/news/2204413/arcadis-nv-arcay-is-a-great-choice-for-trend-investors-here-s-why?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2204413
Jan 02, 2024 - If you are looking for stocks that are well positioned to maintain their recent uptrend, Arcadis NV (ARCAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
0
NVS or LLY: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2206412/nvs-or-lly-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2206412
Jan 05, 2024 - NVS vs. LLY: Which Stock Is the Better Value Option?
0
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-s-p-500-stalls-near-record-high?cid=CS-ZC-FT-investment_ideas-2211005
Jan 16, 2024 - As investors, our job isn't to predict an unknowable future.
0